13F-HR filed by Octagon Capital Advisors LP
Octagon Capital Advisors LP filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 35 holding rows worth $579,434,000.
- Accession
- 0001214659-22-013676
- Filer
- CIK 1839435
- Filed
- 2022-11-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2022
A holdings report, 35 entries on the cover page, a total value of $579,434,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $579,434,000 with VALUE read as thousands by filing date, 13F file number 028-20958. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 2,503,059 | $170,959,000 | thousands by filing date | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 2,668,316 | $69,803,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 2,551,703 | $50,166,000 | thousands by filing date | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 624,500 | $38,650,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 2,045,442 | $24,504,000 | thousands by filing date | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 474,929 | $22,725,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 761,398 | $21,403,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 243,400 | $19,306,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 221,000 | $15,435,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 1,324,868 | $13,540,000 | thousands by filing date | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 533,264 | $11,364,000 | thousands by filing date | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 243,500 | $10,785,000 | thousands by filing date | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 220,953 | $10,281,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 763,456 | $9,803,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 933,743 | $9,281,000 | thousands by filing date | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,225,000 | $8,820,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 83,500 | $8,622,000 | thousands by filing date | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 34,500 | $7,760,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 37,300 | $7,466,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 331,096 | $7,420,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,425,000 | $7,057,000 | thousands by filing date | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 379,629 | $6,199,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 499,996 | $4,020,000 | thousands by filing date | |
| NUVALENT INC COM | 670703107 | Stock | 200,000 | $3,888,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 1,400,000 | $3,276,000 | thousands by filing date | |
| IMMUNOVANT INC | 45258J102 | COM | 579,061 | $3,231,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 40,000 | $3,222,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 75,000 | $2,554,000 | thousands by filing date | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 224,300 | $2,218,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 100,000 | $2,101,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 11,300 | $1,523,000 | thousands by filing date | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 1,000,000 | $861,000 | thousands by filing date | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 450,000 | $581,000 | thousands by filing date | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 20,000 | $465,000 | thousands by filing date | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 30,000 | $145,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-22-013676 | this filing | 2022-11-14 | acceptance time not in the bulk data set |